Skip to content

A clinical study by using Kushthadi churna with Mustadi kwath in Prameha with special reference to hyperglycemia in Type 2 Diabetes melitus

Open randomised controlled clinical study of efficacy of Kushthadi Churna(Harit samhita)with Mustadi kwath(Bhaishajya Ratnavali)in the clinical management of Prameha with special reference to hyperglycemia in Type 2 Diabetes melitus

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/04/051578
Enrollment
60
Registered
2023-04-13
Start date
Unknown
Completion date
Unknown
Last updated
2023-05-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E119- Type 2 diabetes mellitus without complications

Interventions

None listed

Sponsors

Sheth RV Ayurvedic hospital and Sheth VM charitable dispensary
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: BSL fasting - >110mg/dl to 180 mg/dl post prandial- >140mg/dl to 280 mg/dl

Exclusion criteria

Exclusion criteria: patients on insulin therapy patients with nephropathy,h/o diabetic keto acidosis,immunosuppressant drugs. pregnant women and lactating mother

Design outcomes

Primary

MeasureTime frame
To check for the symptomatic relief as per the gradation mentioned in subjective and objective criteriaTimepoint: 15th day 30th day 45th day 60th day

Secondary

MeasureTime frame
To check for the adverse drug effect of kushthadi churnaTimepoint: 15th day ,30th day ,45th day ,60th day

Countries

India

Contacts

Public ContactDrAnaya Ashish Pathrikar

APMs Ayurved Mahavidyalay Sion

anayapathrikar@gmail.com9870214595

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026